Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Sara Meade

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
BMC Cancer|January 15, 2024
A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trialDivyalakshmi Bhaskaran, Joshua Savage, Amit Patel, et al.
Neuro-Oncology Practice|September 21, 2022
Reconfiguration from emergency to urgent elective neurosurgery for glioblastoma patients improves length of stay, surgical adjunct use, and extent of resective surgeryRosa Sun, Shivam Sharma, Helen Benghiat, et al.
The Lancet. Diabetes & Endocrinology|July 5, 2022
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillanceRoss Hamblin, Ashley Vardon, Josephine Akpalu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2025
Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterationsMarie Morfouace, Franck Bielle, Evangelia Razis, et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
BMC Cancer|January 15, 2024
A randomised phase II trial of temozolomide with or without cannabinoids in patients with recurrent glioblastoma (ARISTOCRAT): protocol for a multi-centre, double-blind, placebo-controlled trialDivyalakshmi Bhaskaran, Joshua Savage, Amit Patel, et al.
Neuro-Oncology Practice|September 21, 2022
Reconfiguration from emergency to urgent elective neurosurgery for glioblastoma patients improves length of stay, surgical adjunct use, and extent of resective surgeryRosa Sun, Shivam Sharma, Helen Benghiat, et al.
The Lancet. Diabetes & Endocrinology|July 5, 2022
Risk of second brain tumour after radiotherapy for pituitary adenoma or craniopharyngioma: a retrospective, multicentre, cohort study of 3679 patients with long-term imaging surveillanceRoss Hamblin, Ashley Vardon, Josephine Akpalu, et al.
European Journal of Cancer (Oxford, England : 1990)|May 20, 2025
Molecular analysis of adolescent and young adult high grade gliomas in the SPECTA-AYA study: Poorly characterised tumours with frequent germline alterationsMarie Morfouace, Franck Bielle, Evangelia Razis, et al.
Pageof 2